My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Archivos de la Sociedad Española de Oftalmología
Print version ISSN 0365-6691
Abstract
GOMEZ LEDESMA, I.; SANTIAGO RODRIGUEZ, M.Á. de; FOLLANA NEIRA, I. and LEON GARRIGOSA, F.. Neovascular membrane and pregnancy: Treatment with bevacizumab. Arch Soc Esp Oftalmol [online]. 2012, vol.87, n.9, pp.297-300. ISSN 0365-6691. https://dx.doi.org/10.1016/j.oftal.2011.09.011.
Clinical case: Female in her sixth month of pregnancy, with a history of refractive surgery, who consulted due to a metamorphopsia and decrease in visual acuity in the right eye. A presumed ocular histoplasmosis syndrome (POHS) and a subfoveal choroidal neovascular membrane were observed in the fundoscopy. Two monthly doses of intravitreal bevacizumab were given after the labour, but the third dose was never inyected as the patient became pregnant again. She subsequently had a spontaneous miscarriage. Discussion: Treatment with intravitreal bevacizumab during pregnancy is controversial as it may increase the risk of miscarriage during the first trimester.
Keywords : Bevacizumab; Intravitreal injections; Choroidal neovascularisation; Miscarriage; Pregnancy.